Activation of poly(ADP-Ribose) polymerase contributes to development of doxorubicin-induced heart failure

P. Pacher, L. Liaudet, P. Bai, L. Virag, Jon Mabley, G. Hasko, C. Szabo

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	862-867
Number of pages	6
Journal	Journal of Pharmacology and Experimental Therapeutics
Volume	300
Issue number	3
DOIs	https://doi.org/10.1124/jpet.300.3.862
Publication status	Published - Mar 2002

Access to Document

@article{8a2e3c2e439e4faab3febfd32f4fff2b,

title = "Activation of poly(ADP-Ribose) polymerase contributes to development of doxorubicin-induced heart failure",

author = "P. Pacher and L. Liaudet and P. Bai and L. Virag and Jon Mabley and G. Hasko and C. Szabo",

year = "2002",

month = mar,

doi = "10.1124/jpet.300.3.862",

language = "English",

volume = "300",

pages = "862--867",

journal = "Journal of Pharmacology and Experimental Therapeutics",

issn = "1521-0103",

number = "3",

}

TY - JOUR

T1 - Activation of poly(ADP-Ribose) polymerase contributes to development of doxorubicin-induced heart failure

AU - Pacher, P.

AU - Liaudet, L.

AU - Bai, P.

AU - Virag, L.

AU - Mabley, Jon

AU - Hasko, G.

AU - Szabo, C.

PY - 2002/3

Y1 - 2002/3

U2 - 10.1124/jpet.300.3.862

DO - 10.1124/jpet.300.3.862

M3 - Article

SN - 1521-0103

VL - 300

SP - 862

EP - 867

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

IS - 3

ER -